HDAC1 and rheumatoid arthritis: Inhibiting HDAC2 may be a sensible tactic to decrease RA-SF proliferation without altering MMP production, as HDAC1 and HDAC2 have comparable effects on RA-SF proliferation (Horiuchi et al. 2009).